LAMP1 and Alzheimer disease: LAMP-1, LAMP-2, and LC3 levels are significantly increased in the CSF from patients with Alzheimer’s disease, and the autophagy biomarkers LC3B and Beclin1 correlate with clinical outcomes and disease severity in patients who experienced an acute stroke40,41.